Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2012

Feb 16, 2012

30016_dirs_2012-02-16_39861497-c76c-4824-89dc-5bf485259754.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2012-02-14

Reporting Person: NAQUI ALI (CORPORATE VICE PRESIDENT)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-02-14 Common Stock M 162 Acquired 16948 Direct
2012-02-14 Common Stock M 282 Acquired 17230 Direct
2012-02-14 Common Stock M 364 Acquired 17594 Direct
2012-02-14 Common Stock M 257 Acquired 17851 Direct
2012-02-14 Common Stock M 268 Acquired 18119 Direct
2012-02-14 Common Stock F 455 $87.42 Disposed 17664 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-02-14 Non-Qualified Stock Option (right to buy) $87.42 A 5971 Acquired 2019-02-13 Common Stock (5971) Direct
2012-02-14 Incentive Stock Option (right to buy) $87.42 A 1143 Acquired 2019-02-13 Common Stock (1143) Direct
2012-02-14 Restricted Stock Unit $ A 715 Acquired Common Stock (715) Direct
2012-02-14 Restricted Stock Unit $ M 162 Disposed Common Stock (162) Direct
2012-02-14 Restricted Stock Unit $ M 282 Disposed Common Stock (282) Direct
2012-02-14 Restricted Stock Unit $ M 364 Disposed Common Stock (364) Direct
2012-02-14 Restricted Stock Unit $ M 257 Disposed Common Stock (257) Direct
2012-02-14 Restricted Stock Unit $ M 268 Disposed Common Stock (268) Direct

Footnotes

F1: Grant of options to buy shares of common stock becomes exercisable as to 1,423 shares on 02/14/2013, 02/14/2014, 02/14/2015 and 02/14/2016, and the remaining 279 shares on 02/14/2017.

F2: Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/14/2017) of the grant.

F3: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2013) of the date of grant.

F4: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2012) of the date of grant.

F5: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2011) of the date of grant.

F6: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2010) of the date of grant.

F7: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2009) of the date of grant.

F8: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2008) of the date of grant.